Private Label Peptide Under Eye Serum Manufacturer

Minimum order quantities for private label peptide under eye serums vary significantly depending on whether you are working with a stock formula or a fully custom development, and on the manufacturer's own production setup. For stock formulas that already contain peptide actives — where you are essentially applying your brand label to a validated formula — many contract cosmetic manufacturers will work with MOQs as low as 100 to 250 units. These low minimums are possible because the formula already exists, raw materials are already stocked, and the production run simply needs to be scheduled. Expect to pay a premium per unit at these volumes, often $4 to $9 for a basic peptide serum in a simple packaging format. For semi-custom work — where you are asking the manufacturer to add a specific peptide like Eyeseryl or Argireline at a precise percentage to an existing base — MOQs typically rise to 250 to 500 units. The increase reflects the cost of sourcing the specific active, conducting a small compatibility and stability screen, and adjusting the preservation system if needed. Costs at this tier often run $8 to $18 per unit excluding packaging. Fully custom peptide eye serum formulas, developed from scratch with a cosmetic chemist, generally require 500 to 1,000 units as a starting batch. Custom development also involves a separate formulation fee ranging from $1,500 to $8,000 or more, depending on the manufacturer and the number of revision cycles. Lead times extend to 16–24 weeks at this level. What moves MOQ lower: choosing a manufacturer who already specializes in serums and eye-area treatments, working with their existing stock of peptide actives rather than requesting exotic or proprietary ingredients, and being flexible on packaging (standardized airless pump bottles vs. custom-molded tubes). What pushes MOQ higher: requesting a novel peptide combination the manufacturer has never run, requiring in-house ophthalmologist-tested certification, asking for very small fill sizes (under 10 mL) that are harder to run efficiently, or shipping internationally where import minimums come into play. The common mistake first-time founders make is negotiating MOQ without also negotiating what happens to excess bulk if sales are slower than projected. Always ask whether the manufacturer will hold finished goods in their warehouse at a storage fee, or whether you are required to take delivery of the full batch immediately. Platforms like AJ Cosmo Labs are specifically built for this negotiation. When you post your brief on the AJ Cosmo Labs iOS app, you state your MOQ target upfront, and only manufacturers who can meet it respond — saving you from lengthy back-and-forth with factories that only run 5,000-unit minimums.

The total landed cost of a private label peptide under eye serum is made up of four components: formula/fill cost, packaging cost, testing cost, and regulatory/compliance cost. First-time founders almost always underestimate the last two. Formula and fill cost varies by run type. A stock peptide formula private labeled at 100–250 units typically costs $4 to $9 per unit. A semi-custom peptide addition at 250–500 units runs $8 to $18. A fully custom formula at 500–1,000 units can hit $14 to $30 or more per unit. These figures assume a standard serum fill (15 mL or 30 mL) in a supplied bottle. Packaging cost is often the biggest surprise. Airless pump bottles — which are strongly recommended for peptide serums because they reduce oxidation exposure — cost $0.80 to $2.50 each at small-batch volumes. Dropper bottles with a rubber bulb are cheaper ($0.30 to $0.80) but expose the product to air every time the consumer opens them, which can degrade peptide actives over time. Secondary packaging (outer box with printing) adds another $0.40 to $1.50 per unit for small runs. UV protective glass adds cost but is rarely necessary for water-based peptide serums, which are more vulnerable to temperature than light. Testing costs are fixed regardless of your batch size, which makes them disproportionately heavy on small runs. Accelerated stability testing (12 weeks at 45 °C and 75 % relative humidity) costs roughly $800 to $2,500 depending on the lab. Preservative efficacy testing (PET/challenge test) adds $300 to $800. If you are selling into the EU, a Cosmetic Product Safety Report (CPSR) from a qualified safety assessor costs $1,200 to $3,500 for a standard formula. Regulatory costs in the US are relatively light — MoCRA facility registration is low-cost, and you do not need FDA pre-approval. EU market entry is considerably more expensive when you factor in the CPSR, CPNP notification, and Responsible Person designation. Custom formulation fees, if applicable, are a one-time charge of $1,500 to $8,000 and should be negotiated so that you own the formula IP (not the manufacturer). A realistic all-in budget for a first small batch of 250 units with a semi-custom peptide formula, standard airless pump packaging, and US-only testing is $6,000 to $14,000 total, or $24 to $56 per finished unit. Retail pricing for peptide under eye serums ranges from $35 to $120, so margin is achievable if you keep your MOQ and packaging choices disciplined. AJ Cosmo Labs helps founders compare itemized quotes from multiple manufacturers side by side, so you can see exactly where the cost differences lie before committing to a partner.

Lead time for a private label peptide under eye serum depends almost entirely on which stage of development you are starting from, and how many revision cycles you build in. If you are working with a manufacturer's existing stock formula and simply applying your label and packaging, the fastest realistic timeline is 6 to 10 weeks from signed agreement to finished goods. This assumes the manufacturer has raw materials in stock, your packaging is already sourced or supplied, and no new stability testing is required. Even at this fastest tier, allow 1 to 2 weeks for artwork approval, 1 week for production scheduling, 1 to 2 weeks for filling and labeling, and 1 to 2 weeks for final QC and shipping. For semi-custom work — adding a specific peptide active to an existing base — add 4 to 6 weeks for a compatibility and short-term stability screen. Reputable manufacturers will not skip this step even if they are confident the peptide is compatible, because pH drift or emulsion instability can appear after 4 to 8 weeks that would not be visible at day zero. Semi-custom runs realistically take 10 to 14 weeks. Fully custom formula development runs 16 to 24 weeks at a minimum when done properly. The stage breakdown typically looks like this: weeks 1 to 2 for formula brief alignment and raw material sourcing; weeks 3 to 6 for lab bench development and internal review; weeks 7 to 8 for first sample to founder; weeks 9 to 12 for revision cycles (most founders need 2 to 3 rounds); weeks 13 to 14 for stability placement and PET initiation; weeks 15 to 20 for accelerated stability reads; weeks 21 to 24 for production and QC. The most common reason timelines blow past these estimates is packaging delay. Custom-printed airless bottles from overseas suppliers have 10 to 14 week lead times of their own. If you have not ordered packaging before your formula is finalized, you will wait. Order a provisional packaging run with a generic label while your formula is in revision — most manufacturers can label later. Another timeline killer is slow founder feedback. Manufacturers schedule production runs in batches. If you take two weeks to respond to a sample evaluation, you may miss the next production window by three weeks. Posting your brief on the AJ Cosmo Labs iOS app with a clear launch date gives manufacturers the context they need to tell you upfront whether your timeline is achievable — before you sign a contract.

A high-quality peptide under eye serum should contain at least two complementary peptide actives that address different aspects of periorbital aging, and each peptide should be present at a clinically supported concentration — not a trace amount added for marketing label rights. Argireline (INCI: Acetyl Hexapeptide-3) is the most widely recognized under-eye peptide. It works by inhibiting the SNARE complex that triggers muscle contraction, which over time reduces the depth of expression lines. Efficacy studies have used concentrations of 5 to 10 %. Below 3 %, the ingredient is essentially decorative. Ask your manufacturer for the exact percentage; any refusal to disclose is a red flag. Matrixyl 3000 (INCI: Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7) is a well-researched matrikine pair that stimulates fibroblasts to produce collagen and fibronectin. It addresses skin laxity and the hollowing that contributes to under-eye shadow. Typical use level is 3 to 8 %. Eyeseryl (INCI: Acetyl Tetrapeptide-5) is specifically designed for the periorbital zone. It improves lymphatic drainage and reduces glycation-related puffiness. A clinical study at 3 % showed measurable reduction in under-eye bags after 60 days. This ingredient is highly specific to the eye-area serum category and distinguishes purpose-built formulas from general face serums repurposed for the under-eye area. Leuphasyl (INCI: Acetyl Glutamyl Heptapeptide-3) works synergistically with Argireline to enhance its expression-line-relaxing effect. When combined with Argireline at 5 % each, some formulation data suggests greater efficacy than either peptide alone at 10 %. Syn-Ake (INCI: Dipeptide Diaminobutyroyl Benzylamide Diacetate) mimics the effect of temple viper venom by blocking acetylcholine at the neuromuscular junction. It is effective at 4 % and is a differentiating ingredient for premium positioning. Beyond peptides, a well-constructed under-eye serum should include a humectant layer (sodium hyaluronate, ideally multi-molecular weight), a soothing agent suitable for the delicate periorbital skin (bisabolol, panthenol, or allantoin), and a caffeine component (typically 2 to 5 %) for vasoconstriction and transient de-puffing that gives the product immediate perceptible results while the peptides work over weeks. PH is critical. Peptide actives are most stable and most active between pH 4.5 and 5.5. Any formula outside this range should prompt a question about why, and whether stability data supports it. When reviewing manufacturer formula sheets through AJ Cosmo Labs, founders can request the full INCI list and percentage breakdown before committing to any development agreement.

Finding a vetted small-batch cosmetic manufacturer is genuinely one of the hardest parts of launching a new skincare brand, and the difficulty is compounded when you need a manufacturer with specific expertise in peptide actives. The traditional approach — searching directories, attending trade shows like Cosmoprof or MakeUp in NewYork, or cold-emailing factories found on Google — works eventually but is slow. Directory listings are not vetted, and manufacturer websites rarely disclose actual MOQs or peptide experience. You can spend three to six months in outreach before finding two or three qualified candidates. A faster starting point is the AJ Cosmo Labs iOS app, which is built specifically to connect indie founders with pre-vetted cosmetic manufacturers, formulators, and co-packers. You post a project brief — describing your peptide eye serum concept, target MOQ, fill size, and timeline — and manufacturers who match your criteria respond directly. Because manufacturers on the platform have already been reviewed, you skip the initial credibility screen and move faster to sample evaluation. Regardless of how you find candidates, here is what a proper vetting process looks like: First, request their GMP certification (ISO 22716 or FDA-registered facility certificate). Second, ask for a redacted client list or case study in the eye serum or targeted treatment category — not just general skincare. Third, request a copy of their standard quality agreement and any template manufacturing contract so your legal team can review ownership of formula IP before you invest in development. Fourth, ask specifically who performs the formulation work — an in-house cosmetic chemist or an outsourced lab. Fifth, request their standard stability protocol and a sample stability report from a previous formula. Disqualify any manufacturer who cannot produce a GMP certificate on request, who refuses to put formula ownership language in the contract, who quotes a lead time dramatically shorter than the ranges cited on this page without a credible explanation, or who cannot name the peptide actives by INCI name. For US distribution, confirm the manufacturer is registered or can register under MoCRA. For EU distribution, confirm they have experience with EU Responsible Person requirements or can refer you to one. Small-batch specialists tend to be found in the US (California, New York, and Texas have large concentrations), Canada, South Korea (which has exceptional peptide serum expertise), and increasingly in Poland and the UK for EU-focused brands. The common mistake: choosing the cheapest quote without verifying stability data. A peptide serum that costs $4 per unit but degrades within six months will cost you far more in returns, reputational damage, and reformulation than paying $9 for a manufacturer with documented stability performance.

No, you do not need pre-market FDA approval to sell a private label peptide under eye serum in the United States, provided your product is marketed as a cosmetic and not as a drug. Under US law, a product is a cosmetic if it is intended to affect appearance — to make skin look smoother, to reduce the visible appearance of puffiness, to brighten the look of the under-eye area. A product becomes a drug if it is intended to affect the structure or function of the body. Marketing language like 'clinically treats dark circles' or 'reverses collagen loss' crosses into drug territory and triggers FDA drug regulations, which require premarket approval and are functionally impossible to comply with for a small brand. The practical guidance: use appearance-based claims. 'Visibly reduces the appearance of fine lines' is cosmetic language. 'Reduces wrinkles' without the qualifier 'appearance of' is borderline. 'Stimulates collagen production' is a drug claim and must be avoided on labels and in advertising. The Modernization of Cosmetics Regulation Act (MoCRA), signed in December 2022, introduced new requirements that do apply to your brand. If you are a small business (under $1 million in gross sales averaging over three years), some requirements are phased or waived, but you should verify your status. For brands above the threshold, facility registration and product listing with the FDA are now required. Good Manufacturing Practice (GMP) requirements under MoCRA are being phased in, with final rules expected to be enforceable by 2025 and 2026. Serious adverse event reporting is also now required under MoCRA regardless of company size. If a consumer reports a serious adverse event linked to your eye serum, you must submit a report to the FDA within 15 business days. Labeling requirements that absolutely apply: ingredient declaration in INCI format in descending order of concentration, net weight or volume, distributor name and address, and any required warnings. Eye-area products must not include ingredients that are prohibited or restricted for use near the eyes under 21 CFR. For California specifically, Prop 65 compliance is a separate obligation. If any ingredient in your formula appears on the Prop 65 list above its safe harbor level, a warning must appear on the label for California consumers. Manufacturers you connect with through AJ Cosmo Labs are expected to hold GMP certification and be familiar with MoCRA requirements — you should still verify this directly during onboarding.

Yes, but each channel has specific compliance and documentation requirements that go beyond basic FDA cosmetic compliance, and understanding these before you finalize your formula and packaging will save you significant rework. For Amazon, the primary gateway is Amazon's Consumables and Beauty category approval process. You will need to provide a completed product detail page, safety data if requested, and in some cases third-party safety assessments. Amazon has increasingly requested proof of GMP manufacturing and, for eye-area products, may ask for documentation confirming the formula has been tested for ophthalmological safety. Listing as a third-party seller is relatively straightforward if you have proper UPC codes, compliant labeling, and a professional brand registry enrollment. Amazon's Transparency program, which adds a unique code to each unit to combat counterfeiting, is worth enrolling in if you plan to scale on the platform. For Sephora, the bar is considerably higher. Sephora's vendor onboarding requires a completed ingredient safety documentation package, evidence of stability testing, and often an efficacy substantiation dossier. Sephora has its own restricted ingredients list that is stricter than FDA requirements — you should cross-reference your formula's INCI list against the Sephora Clean or standard Sephora ingredient standards before development, not after. The sales cycle from first pitch to first purchase order at Sephora typically runs 12 to 24 months, and Sephora generally expects brands to have demonstrated e-commerce traction before pitching retail. For clean beauty retailers like Credo or Follain, each maintains its own restricted ingredients list. Fragrance disclosure, full transparency on preservatives, and avoidance of ingredients on their respective 'dirty lists' are required. Peptide actives themselves are generally clean-beauty-compatible, but your preservative system, emollients, and any synthetic fragrance components need to be reviewed against each retailer's standards. For international channels — particularly EU-based online retail — you will need a Responsible Person, a CPSR, and CPNP notification before any EU sale, including direct-to-consumer e-commerce. The channel-specific documentation requirements are one of the strongest reasons to work with an experienced contract cosmetic manufacturer from the start. Manufacturers who regularly supply brands selling into Sephora or major Amazon sellers will already have the stability and safety documentation templates you need. When posting your brief on the AJ Cosmo Labs iPhone app, mention your target sales channel explicitly — it helps match you with manufacturers who have the right documentation track record.